There is potential for Tregs and amphiregulin to be used in patients receiving cancer therapies to ameliorate immune function ...

A team of international researchers led by scientists at City of Hope have demonstrated a way to boost thymic function after ...

This challenge has focused researchers on understanding Tregs' tumor-specific mechanisms to selectively target Tregs within ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of ...

The results highlight an important physiological function of PGAM in the differentiation and suppressive activity of Treg cells by regulating serine synthesis. This role is proposed to intersect with ...

Researchers at the University of Adelaide's Robinson Research Institute have uncovered a new critical role for the immune ...

Coya Therapeutics advances COYA 303 for inflammatory diseases, combining COYA 301 and GLP-1 RA for a synergistic anti-inflammatory effect.

This reduces T-cell activation and cytokine production, as well as encouraging Treg cell recruitment to the fetal–maternal interface. These changes are critical in promoting maternal tolerance.

Coya Therapeutics (COYA) announced the expansion of its investigational pipeline and advancement of COYA 303 for the treatment of inflammatory ...

A team of international researchers led by scientists at City of Hope, one of the largest and most advanced cancer research and treatment organization ...